About Mape Pharmascience LLP
Data last updated:
Mape Pharmascience LLP is a limited liability partnership (LLP) based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 May 2016 and has been in existence for over 10 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAG-4828.
The LLP has a total obligation of contribution of ₹20 Cr. It is led by designated partners Deepak Mohan and Jacob Mathew.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹1.54 Lakh. For the same year it recorded a net profit of ₹74,438 (net margin 48.4%) and EBITDA of -₹32,960 (EBITDA margin -21.4%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 37% over five years.
As per MCA filings, the LLP has open charges of ₹40 Cr and satisfied charges of ₹303.5 Cr on record. Court records list 4 cases involving the LLP, including 1 filed by the LLP and 3 filed against it; 2 cases are pending.
For more details, the LLP can be reached via its website mapegroup.com.
Company details
Contact details
Mape Pharmascience LLP's registered office is in Mumbai, Maharashtra. Its website is mapegroup.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOffice No. 10 Part A Vasant Vihar, New Nagardas Cross Road Andheri East, Mumbai, Maharashtra, India – 400069
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Mape Pharmascience LLP, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Mape Pharmascience LLP
FY 2025 filings availableMape Pharmascience LLP reported revenue of ₹1.54 Lakh for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 37% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | ₹1.54 Lakh | ||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | ₹74,438 | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 48.4% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Mape Pharmascience LLP, buy the company report.
Designated partners of Mape Pharmascience LLP
Mape Pharmascience has 2 current designated partners and 2 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Mohan | Designated Partner | 22 Jul 2024 | 2 Years 3 Months | Current |
| Jacob Mathew Also directs: Mape Citrus Developers LLP, Jacob Mathew Family Office LLP, Mape Autocomps LLP and 5 more | Designated Partner | 27 May 2016 | 10 Years 5 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 May 2024 | 100930133 | Piramal Trusteeship Services Private Limited | ₹40 Cr | Open | |
| 22 Feb 2018 | 100157938 | Rbl Bank Limited | ₹51 Cr | Satisfied | |
| 09 Feb 2018 | 100158105 | Axis Bank Limited | ₹82.5 Cr | Satisfied | |
| 22 Nov 2017 | 100135894 | Idbi Trusteeship Services Limited | ₹30 Cr | Satisfied | |
| 23 Aug 2016 | 100053624 | Idbi Trusteeship Services Limited | ₹140 Cr | Satisfied |
To see the full charge records of Mape Pharmascience LLP, buy the company report.
Total charge records: 5 View all charges
Legal cases
Mape Pharmascience LLP has 4 court cases on record: 1 filed by Mape Pharmascience, 3 filed against it. 2 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 2 | 2 |
| NCLT | 1 | 1 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed against the company by Chandrapore Estates Private Limited(Org.Def.No. | Pending |
| High Court, MAHARASHTRA | Commercial suit | Filed by the company against R L Fine Chem Private Limited and 14 Ors and 14 others | Disposed |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed against the company by Anam Fine Chemicals Private Limited and Anr | Pending |
| NCLT, Bengaluru | Company petition | Filed against the company by individuals | Disposed |
To see the full case history of Mape Pharmascience LLP, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mape Pharmascience LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Mape Pharmascience LLP; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Mape Pharmascience LLP has 4 designated partner changes on record since 2016: 2 appointments and 2 cessations. The latest: Deepak Mohan was appointed as Designated Partner on 22 Jul 2024.
6 earlier events are in the company report.
Frequently asked questions
Mape Pharmascience is an active limited liability partnership based in Mumbai, Maharashtra, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 27 May 2016 (10+ years old) and is registered under LLPIN AAG-4828.
Mape Pharmascience has 2 current designated partners:
- Deepak Mohan - Designated Partner
- Jacob Mathew - Designated Partner
The latest financial statements of Mape Pharmascience on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2017 are in the company report.
The LLPIN (Limited Liability Partnership Identification Number) of Mape Pharmascience is AAG-4828. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Mape Pharmascience has 4 court cases on record: 1 filed by the LLP and 3 filed against it. 2 are pending. Most are in the high courts.
Mape Pharmascience was incorporated on 27 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Deepak Mohan was appointed as Designated Partner on 22 Jul 2024. Vishwanath Kanthappa Poojari ceased to be Partner on 10 Apr 2021. Ramprasad Mathrubutham ceased to be Designated Partner on 23 Feb 2020. Mape Pharmascience has 4 designated partner changes on record in total.
Mape Pharmascience can be reached through the website mapegroup.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Mape Pharmascience is at Office No. 10 Part A Vasant Vihar, New Nagardas Cross Road Andheri East, Mumbai, Maharashtra, India – 400069.
Mape Pharmascience operates in the pharma industry, in the drug formulation and development segment.